N-(4-Methyl-3-nitrophenyl)-3-(trifluoromethyl)benzamide, 95%, 250mg

6-Fluorobenzo[d]oxazol-2-amine, 95.0%, 1g

4-FLUORO-1-TOSYL-3,4-DIHYDRO-1H-BENZO[B]AZEPIN-5(2H)-ONE, 90.0%, 250mg

tert-Butyl ((1R,2S)-rel-2-(aminomethyl)cyclohexyl)carbamate, 500mg

1-(4-Chlorobenzyl)-3-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)urea, 98%, 250mg

Methyl-4-methoxy-1-naphthoate, 97%, 100mg

Solución estándar multielemento para ICP-MS, 100 ml, 3 elementos en ácido nítrico al 2 %

4-Hydroxy-3-methyl benzonitrile, 95.0%, 250mg

(4-(Thiazol-2-yl)phenyl)methanamine hydrochloride, 95.0%, 250mg

Sal potásica del ácido glucónico, mínimo 99%, para síntesis, 500 g, envase de plástico.

5-Bromo-4,6-dihydroxypyrimidine, 97.0%, 5g

2,2-Difluoro-6-azaspiro[3.4]octane hydrochloride, 98%, 100mg

5-CHLORO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 1g